SCHEMBL20647416

SCHEMBL20647416

C[C@H]1CC[C@H](C(F)(F)Oc2ccc(-c3ccc(-c4ccc(-c5ccc(-c6ccc(OC(F)(F)[C@H]7CC[C@H](C)CC7)cc6)s5)c5nsnc45)s3)cc2)CC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 2/20 0.33
▸ PRF1 P14222 1/20 0.32
▸ CHEK1 O14757 1/20 0.30
▸ MMP12 P39900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22241066 1.00 APP (0.33) APPPRF1CHEK1MMP12
SCHEMBL21134113 0.96 APP (0.30) APP
SCHEMBL21846598 0.93 MMP13 (0.30) MMP12
SCHEMBL22241019 0.87 ESR1 (0.31) —
SCHEMBL20647304 0.87 ESR1 (0.31) —
SCHEMBL17694319 0.85 MMP12 (0.30) MMP12
SCHEMBL18464127 0.84 GABBR2 (0.34) CHEK1MMP12
SCHEMBL21134077 0.80 APP (0.40) APPPRF1
SCHEMBL18464128 0.78 GABBR2 (0.30) —
SCHEMBL22238922 0.76 APP (0.37) APPPRF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11015123-B2 Liquid-crystal material MERCK PATENT GMBH (DE) 2021-05-25 — — US disclosed
US-20200255741-A1 LIQUID-CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2020-08-13 — — US disclosed
US-10723950-B2 Liquid-crystalline mixtures MERCK PATENT GMBH (DE) 2020-07-28 — — US disclosed
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound MERCK PATENT GMBH (DE) 2019-07-09 — — US disclosed
US-20190016955-A1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound CRY1, SLC25A1, CRY2 APP 1959/4885PRF1 3928/4885CHEK1 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback